NTT Research, Inc., a division of NTT (TY;9432), today announced that members of its Physics & Informatics (PHI) Lab, in ...
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback